Copy
Identify and Quantify CRISPR InDels up to 1000bs - Read More
CRISPR Medicine News |  24 Oct. 2022
Base Editors | Off-target | Delivery | CAR-TTrials | Microbiome | Advertising | Webinars
WEBINAR 26th October 3:00 PM CEST
 
GEENIE: The First in a New Class of Non-viral Delivery Platform for Cancer and Genome Editing Molecules


REGISTER HERE
 

What will you learn from this webinar:

  • Introducing CyGenica's GEENIE technology: A novel non viral delivery platform
  • Potential applications of GEENIE
  • Collaboration and partnering opportunities

 

Webinar Programme:

  • 15.00: Welcome and introduction by CRISPR Medicine News
  • 15.05: Dr. Nusrat J M Sanghamitra, Founder, CEO/CSO, CyGenica, Dr. Kaustuv Mittra, Research Scientist, CyGenica | GEENIE: The First in a New Class of Non-viral Delivery Platform for Cancer and Genome Editing Molecules
  • 15.50: Q & A with Nusrat J M Sanghamitra
  • 16.25: Close by CRISPR Medicine News

 

Speakers:

Dr. Nusrat J M Sanghamitra, Founder, CEO/CSO

Dr. Kaustuv Mittra, Research Scientist

 

Title:

GEENIE: The First in a New Class of Non-viral Delivery Platform for Cancer and Genome Editing Molecules

 

CMN interview

Your Selection of CMN Articles 
A GEENIE in a Bottle: CyGenica’s Unique Non-Viral Cargo Delivery Platform
By: Karen O'Hanlon Cohrt - Oct. 12, 2022
New Promise for Mendelian Disorders
By: Christos Evangelou, - Oct. 5, 2022
New Hope for Cancer Immunotherapies
By: Rebecca Roberts, Ph.D - Sep. 26, 2022

Read the interview here

Thank you for now - more great reads are on the way!
And if you have questions or suggestions, you can reach out to us directly at:
TheEditor@crisprmedicinenews.com
We love hearing from readers!

Happy Reading!

The CMN Team

LinkedIn
Twitter
Copyright © 2022 CRISPR Medicine News, All rights reserved.

Our mailing address is:
TheEditor@crisprmedicinenews.com

Access to CMN Newsletter archive using this link

Want to unsubscribe from these emails?
Unsubscribe from this list.